NAS:FBRX (USA) Also Trade In: Germany
Forte Biosciences Inc $ 36.86 1.73 (4.92%)
Warning! GuruFocus has detected 1 Good sign with FBRX. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for FBRX (Forte Biosciences Inc) from 2020 to Dec 02 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Forte Biosciences stock (FBRX) PE ratio as of Dec 02 2020 is 0. More Details
Forte Biosciences PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Forte Biosciences PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Address 1124 W Carson Street, MRL Building 3-320, Torrance, CA, USA, 90502
Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial in mid-2020.